Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?

Addiction

Volumn 114, Issue 9, 2019, Pages 1575-1581

  Marino, Ryan ^a   Landau, Aaron ^a   Lynch, Michael ^a   Callaway, Clifton ^a   Suffoletto, Brian ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Computerized clinical decision support; electronic medical record; emergency department; harm reduction; naloxone; opioid; overdose; take home

Indexed keywords

NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADULT; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL PRACTICE; DRUG OVERDOSE; ELECTRONIC HEALTH RECORD; EMERGENCY MEDICINE; EPIDEMIOLOGY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL EMERGENCY SERVICE; HUMAN; MALE; MIDDLE AGED; PENNSYLVANIA; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG OVERDOSE; ELECTRONIC HEALTH RECORDS; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PATIENT DISCHARGE; PENNSYLVANIA; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85067385560     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.14635     Document Type: Article

References (26)

1. Scholl L., Seth P., Kariisa M., Wilson N., Baldwin G. Drug and Opioid-Involved Overdose Deaths-United States, 2013–2017. MMWR Morb Mortal Wkly Rep 2019;67: 1419–1427.
2. Olfson M., Wall M., Wang S., Crystal S., Blanco C. Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug Alcohol Depend 2018; 190: 112–119.
3. Kestler A., Buxton J., Meckling G., Giesler A., Lee M., Fuller K. et al. Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Ann Emerg Med 2017; 69: 340–346.
4. Harm Reduction Coalition. Guide to Developing and Managing Overdose Prevention and Take Home Naloxone Projects; 2012. Available at: http://harmreduction.org/wp-content/uploads/2012/11/od-manual-final-links.pdf (accessed 18 October 2018) (Archived at http://www.webcitation.org/78CuFIfxz on 7 May 2019).
5. Wheeler E., Jones T. S., Gilbert M. K., Davidson P. J. Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. Morb Mortal Wkly Rep 2015; 64: 631–635.
6. McDonald R., Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 2016; 111: 1177–1187.
7. Vivolo-Kantor A. M., Seth P., Gladden R. M., Matson C. L., Baldwin G. T., Kite-Powell A. et al. Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses—United States, July 2016–September 2017. Atlanta, GA: Centers for Disease Control and Prevention; 2018.
8. Bakhireva L. N., Bautista A., Cano S., Shrestha S., Bachyrycz A. M., Cruz T. H. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Subst Abuse 2018; 39: 331–341.
9. Cressman A. M., Mazereeuw G., Guan Q., Jia W., Gomes T., Juurlink D. N. Availability of naloxone in Canadian pharmacies: a population-based survey. Can Med Assoc J Open 2017; 5: E779–E784.
10. Green T. C., Case P., Fiske H., Baird J., Cabral S., Burstein D. et al. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. J Am Pharm Assoc 2017; 57: S19–S27.
11. Samuels E. A., Dwyer K., Mello M. J., Baird J., Kellogg A. R., Bernstein E. Emergency department-based opioid harm reduction: moving physicians from willing to doing. Acad Emerg Med 2016; 23: 455–465.
12. Holland T. J., Penm J., Dinh M., Aran S., Chaar B. Emergency department physicians’ and pharmacists’ perspectives on take-home naloxone. Drug Alcohol Rev 2019; 38: 169–176.
13. Elliott L., Bennett A. S., Wolfson-stofko B. Life after opioid-involved overdose: survivor narratives and their implications for ER/ED interventions. Addiction 2019; https://doi.org/10.1111/add.14608.
14. Sahota N., Lloyd R., Ramakrishna A., Mackay J. A., Prorok J. C., Weise-Kelly L. et al. Computerized clinical decision support systems for acute care management: a decision-maker–researcher partnership systematic review of effects on process of care and patient outcomes. Implement Sci 2011; 6: 91.
15. Sim I., Gorman P., Greenes R. A., Haynes R. B., Kaplan B., Lehmann H. et al. Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc 2001; 8: 527–534.
16. Hunt D. L., Haynes R. B., Hanna S. E., Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 1998; 280: 1339–1346.
17. Castillo E. M., Chan T. C., Tolia V. M., Trumm N. A., Powell R. A., Brennan J. J. et al. Effect of a computerized alert on emergency department hepatitis A vaccination in homeless patients during a large regional outbreak. J Emerg Med 2018; 55: 764–768.
18. Reardon J. M., Harmon K. J., Schult G. C., Staton C. A., Waller A. E. Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: a retrospective analysis of a surveillance case definition. BMC Emerg Med 2016; 16: 11.
19. Cochrane Effective Practice and Organisation of Care (EPOC). Interrupted time series (ITS) analyses. EPOC Resources for review authors; 2017. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 17 March 2019) (Archived at http://www.webcitation.org/78CuQl3XK on 7 May 2019).
20. Baum C. F., Schaffer M. E. ACTEST: Stata module to perform Cumby–Huizinga general test for autocorrelation in time series. Statistical Software ComponentsS457668, revised. Chestnut Hill, MA: Boston College Department of Economics; 2015.
21. Scott I. A., Pillans P. I., Barras M., Morris C. Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Ther Adv Drug Saf 2018; 9: 559–573.
22. Bennett P., Hardiker N. R. The use of computerized clinical decision support systems in emergency care: a substantive review of the literature. J Am Med Inform Assoc 2017; 24: 655–668.
23. Dwyer K., Walley A. Y., Langlois B. K., Mitchell P. M., Nelson K. P., Cromwell J. et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med 2015; 16: 381–384.
24. Dehon E., Weiss N., Jones J., Faulconer W., Hinton E., Sterling S. A systematic review of the impact of physician implicit racial bias on clinical decision making. Acad Emerg Med 2017; 24: 895–904.
25. Stein B. D., Dick A. W., Sorbero M., Gordon A. J., Burns R. M., Leslie D. L., et al. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees. Subst Abus 2018; 39: 419–425.
26. Devries J., Rafie S., Ajayi T. A., Kreshak A., Edmonds K. P. Results of a naloxone screening quality-improvement project in an academic emergency department. J Emerg Med 2019; https://doi.org/10.1016/j.jemermed.2018.12.029.